Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Current Opinion in Drug Discovery & Development|September 19, 2001
Protein models in drug discoveryM Norin, M SundströmLipids|August 1, 1993
The role of arginines in stabilizing the active open-lid conformation of Rhizomucor miehei lipaseM Holmquist, M Norin, K HultBiophysical Journal|August 1, 1994
Molecular dynamics simulations of an enzyme surrounded by vacuum, water, or a hydrophobic solventM Norin, F Haeffner, K Hult, et al.Protein Engineering|April 9, 1999
Hydrophobicity engineering of cholera toxin A1 subunit in the strong adjuvant fusion protein CTA1-DDL Agren, M Norin, N Lycke, et al.Chemosphere|May 19, 2009
Synthesis of 2-(4-chlorophenyl)-2-(4-chloro-3-thiophenol)-1,1-dichloroethene (3-SH-DDE) via Newman-Kwart rearrangement - a precursor for synthesis of radiolabeled and unlabeled alkylsulfonyl-DDEsT Cantillana, M Sundström, A BergmanThe Journal of Biological Chemistry|December 25, 1989
Preliminary crystallographic data for transketolase from yeastG Schneider, M Sundström, Y LindqvistFEBS Letters|November 30, 1992
Three-dimensional structure of apotransketolase. Flexible loops at the active site enable cofactor bindingM Sundström, Y Lindqvist, G SchneiderVirus Research|June 15, 2000
Fine characterization of a V3-region neutralizing epitope in human immunodeficiency virus type 2A Mörner, A Achour, M Norin, et al.Viral Immunology|May 20, 1999
Characterization of neutralizing sites in the second variable and fourth variable region in gp125 and a conserved region in gp36 of human immunodeficiency virus type 2P Skott, A Achour, M Norin, et al.Protein Engineering|November 1, 1993
Theoretical studies of Rhizomucor miehei lipase activationM Norin, O Olsen, A Svendsen, et al.Pageof 4